Slovenia
Industry
Slovenian drugmaker Krka is to make its first venture into Western Europe with the planned acquisition for German generics firm TAD Pharma in a deal reported to be worth EUR97mn...
2007-11-14Companies
Leading Slovenian drugmaker Krka has officially opened its Sinteza 4 active pharmaceutical ingredient (API) production facility. The EUR80mn (US$107mn) plant will allow the firm to...
2007-06-21Companies
On the back of impressive 2006 financial results, Slovenian drugmaker Krka is looking to further penetrate emerging markets, continue to upscale its R&D capabilities, get more...
2007-02-13Companies
Slovenia's Krka has reached an out-of-court settlement with French firm Servier over a generic version of the latter's perindopril - an ACE inhibitor for the treatment of hypertension....
2006-11-17Companies
Staking a prominent claim in the pharmaceutical sector experiencing the strongest growth, Slovenian firm Lek - part of Swiss firm Novartis' Sandoz generics division - has started...
2006-10-06Companies
Frustrated at the lack of opportunities in its home market, Slovenian firm Krka is planning a concerted promotional campaign in Romania ahead of EU accession next year, which is expected...
2006-09-28Companies
Outperforming its competitors, Slovenia firm Lek - part of the generics division of Swiss company Sandoz - has released financial results for the first half of 2006 in which sales...
2006-07-25



